Arnold Bok
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Arnold Bok has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Schweder
Department of Neurosurgery, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand; Centre for Brain Research, University of Auckland, New Zealand
3 shared publications - Adele McMahon
Department of Neurology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand
2 shared publications - Andrew Smith
Department of Radiology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand
2 shared publications - B.B. Janice Lam
Living Cell Technologies New Zealand Limited, PO Box 23566, Hunters Corner, Auckland, 2155, New Zealand
2 shared publications - Barry Snow
Department of Neurology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand
2 shared publications - Benson S. Chen
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
2 shared publications
Latest Publications
- 12 March 2020
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 75, 157-162
Dural venous sinus thrombosis after cerebellopontine angle surgery: Should it be treated?
- 12 March 2020
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 75, 157-162
Dural venous sinus thrombosis after cerebellopontine angle surgery: Should it be treated?
- 1 March 2020
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 73, 144-149
Metastatic melanoma: Surgical treatment of brain metastases – Analysis of 110 patients
- 1 March 2020
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 73, 144-149
Metastatic melanoma: Surgical treatment of brain metastases – Analysis of 110 patients
- 1 April 2019
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 61, 88-93
A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL® [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease
- 1 April 2019
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 61, 88-93
A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL® [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease